Pharmaron Beijing Co., Ltd. (SHE:300759)

Market Cap	38.21B
Revenue (ttm)	12.70B
Net Income (ttm)	1.87B
Shares Out	1.77B
EPS (ttm)	1.06
PE Ratio	21.88
Forward PE	21.18
Dividend	0.20 (0.87%)
Ex-Dividend Date	Jun 27, 2024

Volume	14,339,147
Average Volume	30,936,438
Open	25.44
Previous Close	23.25
Day's Range	23.05 - 25.44
52-Week Range	17.70 - 36.42
Beta	0.91
RSI	42.15
Earnings Date	Aug 7, 2025

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally. The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 21,370
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300759

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.